Baxter International (NYSE:BAX) Updates Q2 Earnings Guidance

Baxter International (NYSE:BAXGet Free Report) issued an update on its second quarter earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.65-$0.67 for the period, compared to the consensus earnings per share estimate of $0.68. The company issued revenue guidance of $3.74 billion, compared to the consensus revenue estimate of $3.77 billion. Baxter International also updated its FY24 guidance to $2.88-$2.98 EPS.

Wall Street Analysts Forecast Growth

BAX has been the topic of a number of recent analyst reports. UBS Group dropped their price objective on shares of Baxter International from $40.00 to $36.00 and set a neutral rating on the stock in a research report on Tuesday, February 6th. Citigroup lifted their price target on Baxter International from $41.00 to $44.00 and gave the stock a neutral rating in a report on Wednesday, April 3rd. Bank of America increased their price objective on Baxter International from $42.00 to $45.00 and gave the company a neutral rating in a report on Tuesday, March 5th. JPMorgan Chase & Co. boosted their target price on Baxter International from $38.00 to $44.00 and gave the stock a neutral rating in a research note on Friday, February 9th. Finally, StockNews.com upgraded shares of Baxter International from a hold rating to a buy rating in a research note on Friday, January 19th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of Hold and a consensus price target of $46.30.

Check Out Our Latest Stock Report on BAX

Baxter International Stock Performance

Shares of Baxter International stock traded down $0.02 during trading on Friday, reaching $36.89. The company’s stock had a trading volume of 6,246,789 shares, compared to its average volume of 3,358,723. The company has a 50-day moving average price of $41.53 and a two-hundred day moving average price of $38.75. Baxter International has a fifty-two week low of $31.01 and a fifty-two week high of $50.21. The firm has a market cap of $18.73 billion, a PE ratio of 7.09, a P/E/G ratio of 1.98 and a beta of 0.64. The company has a current ratio of 1.48, a quick ratio of 1.04 and a debt-to-equity ratio of 1.31.

Baxter International (NYSE:BAXGet Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.65 EPS for the quarter, beating analysts’ consensus estimates of $0.61 by $0.04. Baxter International had a net margin of 17.79% and a return on equity of 18.97%. The company had revenue of $3.59 billion for the quarter, compared to analyst estimates of $3.55 billion. During the same period in the previous year, the business posted $0.59 earnings per share. Baxter International’s quarterly revenue was down 1.6% on a year-over-year basis. On average, analysts forecast that Baxter International will post 2.9 EPS for the current year.

Baxter International Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, April 1st. Shareholders of record on Friday, March 1st were paid a $0.29 dividend. The ex-dividend date was Thursday, February 29th. This represents a $1.16 annualized dividend and a dividend yield of 3.14%. Baxter International’s dividend payout ratio (DPR) is currently 22.31%.

Baxter International Company Profile

(Get Free Report)

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

Featured Articles

Earnings History and Estimates for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.